Novel Treatment Approach May Reduce Risk of Death From ICI-Related Myocarditis
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Diagnosis & Disease Information
Identifying and Managing Adverse Reactions to Lenvatinib and Pembrolizumab
Researchers have characterized common adverse reactions to combination lenvatinib and pembrolizumab in patients with advanced renal cell carcinoma.
Risk for Psychiatric Disorders Up for Spouses of Patients With Cancer
Most prominent increase seen for spouses of patients diagnosed with cancer with poor prognosis, at advanced stage.
Risks of Sexual Dysfunction Higher for Survivors of Gynecologic Cancers
Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.
Prone vs Supine Positioning in Breast Radiotherapy in Women with Large Breast Size
A randomized trial sought to determine whether prone position for adjuvant radiotherapy to the breast results in less skin toxicity in women with large breasts.
ADT, Disease Transition Are Risk Factors for Depression, Anxiety in Prostate Cancer
A survey of men with prostate cancer sought to identify when these patients were most vulnerable to symptoms of depression and/or anxiety.
Attenuated Salivary Cortisol Patterns May Be a Biomarker for Chemotherapy-Induced Peripheral Neuropathy
A substudy of a pilot yoga intervention may have identified a biomarker for CIPN in patients with cancer treated with neurotoxic chemotherapy.
Cardiovascular irAEs Prognostic Factors With Immune Checkpoint Inhibitors for NSCLC
A retrospective, observational study sought to identify prognostic factors for cardiovascular immune-related adverse events in patients with NSCLC treated with immune checkpoint inhibitors.
Symptom Burden, Physical Activity Predict Overall Recovery After Allogeneic Hematopoietic Stem Cell Transplantation
Analysis of patient-reported questionnaire results showed predictors of recovery for patients undergoing allo-HSCT.
Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
- Loading...
Loading...
Next post in Genitourinary Cancer
Loading... 
Loading...